A phase II study of irinotecan in patients with advanced renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/12833456

Cancer 2003 Jul 1 98 1 61-5

Download in:

View as

Triples

General Info

PMID
12833456